Rein Therapeutics Inc

The current institutional shareholding score of Rein Therapeutics Inc is 3.00, ranking 192 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 16.21%, representing a quarter-over-quarter decrease of 51.20%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.09% of shares outstanding, with 214.69% increase in holdings.